Target intelligence / Profile preview

MicroRNA (generic placeholder) (miR-X)

Target
miR-X
Molecular classification
Non-coding RNA, MicroRNA
01

Overview

miR-X is a generic nomenclature and placeholder used in scientific literature to represent any member of the microRNA (miRNA) family, such as miR-21 or miR-124. MicroRNAs are small, non-coding RNA molecules (typically 19-25 nucleotides) that play a critical role in post-transcriptional gene regulation by binding to the 3'-untranslated regions (UTRs) of target messenger RNAs (mRNAs), leading to their degradation or translational repression [1, 4, 8]. While 'miR-X' is not a specific therapeutic target itself, the class of microRNAs it represents is highly relevant in drug development, with numerous miRNAs identified as 'oncomiRs' in cancer or regulators of metabolic and neurological pathways [2, 20]. Additionally, 'Mir-X' is a commercial brand of microRNA quantification and synthesis kits produced by Takara Bio [6, 11, 22]. Therapeutic strategies targeting miRNAs include the use of antisense oligonucleotides (antagomiRs) to inhibit overexpressed miRNAs or synthetic mimics to restore the function of downregulated tumor-suppressor miRNAs [2, 12, 21].

Other names
miRNAmicroRNAMir-X (kit)miR-X/miR-X*X-linked microRNA
02

Mechanism of action

Antisense-mediated inhibition of mature microRNA or its biogenesis; synthetic mimicry of endogenous microRNA function to restore gene silencing of target mRNAs.

03

Biological functions

Post-transcriptional gene regulationmRNA degradationTranslational repressionCell differentiationApoptosisCell proliferation
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseInfectionInflammation
05

Safety considerations

Off-target effectsImmune system activationSaturation of the RNA-induced silencing complex (RISC)Delivery to target tissues
06

Interacting drugs

AntagomiRs (e.g., Miravirsen, Cobomarsen)

3 more in the full profile.

07

Biomarkers

Circulating microRNAsExosomal microRNAs

Beyond the preview

Go deeper on MicroRNA (generic placeholder) (miR-X).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA (generic placeholder) (miR-X).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call